Liposomal Creatine Monohydrate 80% — High Bioavailability Muscle Performance Supplement

Product Overview

liposomal Creatine Monohydrate 80% is a premium-grade dietary supplement ingredient delivering creatine monohydrate in an advanced liposomal delivery system. Creatine (CAS 6020-87-7), chemically known as N-(aminoiminomethyl)-N-methylglycine monohydrate or 2-[carbamimidoyl(methyl)amino]acetic acid, is a naturally occurring non-protein molecule that serves as the primary component of phosphocreatine, the high-energy phosphate store that cells utilize for rapid ATP regeneration. It is a white, crystalline powder that is sparingly soluble in water, with the molecular formula C₄H₉N₃O₂·H₂O and a molecular weight of 149.15 g/mol (monohydrate) or 131.14 g/mol (anhydrous).

Creatine is synthesized endogenously in the liver, kidneys, and pancreas from the amino acids glycine, arginine, and methionine, and is also obtained through dietary sources including red meat and fish. Approximately 95% of the body’s total creatine and phosphocreatine stores are found in skeletal muscle, with the remaining amounts distributed in the brain, testes, blood, and various other tissues. The compound is essential for maintaining cellular energy homeostasis through the creatine kinase/phosphocreatine system, which rapidly regenerates ATP from ADP during periods of high energy demand.

Creatine monohydrate is the most extensively studied form of creatine and the only form with an established safety record and universally recognized efficacy. However, conventional creatine monohydrate presents significant formulation challenges, including poor aqueous solubility, gastrointestinal discomfort at therapeutic doses, and suboptimal absorption kinetics.

Why Liposomal Technology?

Conventional creatine monohydrate presents fundamental bioavailability challenges. The compound has poor aqueous solubility, and while low-dose loading periods have shown a 53% absorption rate—reducing the amount of supplemental creatine waste—it takes approximately four weeks to reach muscle saturation. Additionally, gastrointestinal discomfort is commonly reported at effective doses.

Liposomal encapsulation provides four critical advantages:

1. Enhanced Absorption Efficiency — Liposomal creatine consists of creatine monohydrate encapsulated in liposomal components (phosphatidylcholine), which are small lipid packages that increase and speed absorption by the gut. Published product data demonstrates up to 8.5 times higher creatine levels in skeletal muscles compared to creatine monohydrate alone.

2. Protection from Gastric Degradation — Encapsulating the supplemental creatine with the liposomal blend improves the bioavailability of the supplemental creatine by protecting it from the user's digestive system. The phospholipid bilayer shields creatine from degradation during digestive transit, preserving its intact molecular structure until reaching optimal absorption sites.

3. Reduced Gastrointestinal Discomfort — The liposomal formulation is not known to alter the inherent safety profile of creatine and may further enhance its tolerability and absorption efficiency. By reducing direct contact between creatine and the gastrointestinal mucosa, liposomal encapsulation minimizes the risk of gastric discomfort commonly reported with high-dose conventional creatine.

4. Enhanced Cellular Uptake — Liposomal creatine is able to enter muscle cells faster, improving muscle strength, performance, and energy supply compared to traditional creatine monohydrate. The liposomal delivery system complements the sodium-dependent creatine transporter (SLC6A8) utilized by free creatine, providing an additional route of cellular entry.

Product Specifications

Key Features

• High Purity — Standardized to ≥80% creatine monohydrate by HPLC, with USP-grade purity available (98.0–102.0% on dried basis).

• Liposomal Enhancement — Phospholipid bilayer encapsulation protects creatine from gastric degradation and enhances intestinal absorption through lipid-mediated pathways, achieving up to 8.5 times higher creatine levels in skeletal muscles compared to creatine monohydrate alone.

• Superior Bioavailability — Liposomal creatine is not known to alter the inherent safety profile of creatine and may further enhance its tolerability and absorption efficiency. Published product data demonstrates up to 2× better absorption vs. standard creatine at every time point tested (1, 3, 6 and 12 hours).

• Enhanced Muscle Performance — A systematic review and meta-analysis of 69 studies with 1,937 participants demonstrated that creatine combined with resistance training produced significant improvements in bench/chest press strength (WMD = 1.43 kg, p = 0.002), squat strength (WMD = 5.64 kg, p = 0.001), vertical jump (WMD = 1.48 cm, p = 0.01), and Wingate peak power (WMD = 47.81 Watts, p = 0.004).

• Cognitive and Neuroprotective Support — Creatine plays a critical role in brain energy metabolism through the creatine kinase/phosphocreatine system. Clinical studies are evaluating creatine for brain creatine enhancement and cognitive function in aging and neurodegenerative conditions.

• Reduced Gastrointestinal Discomfort — Liposomal encapsulation minimizes direct contact between creatine and the gastrointestinal mucosa, improving tolerability at effective doses.

• Water-Dispersible — Suitable for capsules, tablets, powder drink mixes, and functional beverages.

• Batch Traceability — Complete COA, HPLC chromatogram, and identity data provided for each batch.

Application & Formulation Guidance

Recommended Dosage

Clinical studies have evaluated creatine monohydrate across a range of dosing protocols. The standard loading protocol consists of 20 g/day (divided into four 5 g doses) for 5–7 days, followed by a maintenance dose of 3–5 g/day. A randomized controlled pilot study in patients with mild traumatic brain injury used a fixed daily dose of 5 g of creatine monohydrate for seven weeks. A pilot trial in Alzheimer‘s disease patients investigated 20 g/day of creatine monohydrate for 8 weeks. For general muscle performance support, 3–5 g/day is commonly used. Liposomal formulations may allow for more efficient utilization of lower doses due to enhanced bioavailability, potentially reducing the need for a traditional loading phase.

Shipping & Lead Time

• Stock Orders: 3–5 business days after payment confirmation.

• Bulk / Custom Orders: 2–3 weeks, depending on quantity and customization requirements.

• Shipping Methods: International Express (FedEx, DHL, UPS), air freight, and sea freight.

• Coverage: Worldwide shipping, including remote areas.